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Background: Human papillomavirus (HPV) infection is a necessary cause in the development of cervical cancer;
however, not all women infected with HPV develop cervical cancer indicating that other risk factors are involved.
Our objective was to determine the association between exposure to ambient levels of common traffic-related air
toxics and cervical dysplasia, a precursor lesion for cervical cancer.
Methods: The study sample consisted of women enrolled in a Phase II clinical trial to evaluate diagnostic
techniques for cervical disease in Houston, Texas. The current assessment is a secondary data analysis in which
cases were defined as women diagnosed with cervical dysplasia, while those without cervical dysplasia served
as controls. Residential census tract-level estimates of ambient benzene, diesel particulate matter (DPM), and
polycyclic aromatic hydrocarbons (PAHs) were used to assess exposure. Census tract-level pollutant estimates were
obtained from the United States Environmental Protection Agency. Multivariable logistic regression was used to
estimate prevalence odds ratios (aOR) and 95% confidence intervals (CI) adjusted for age, race/ethnicity, education,
smoking status, and HPV status.
Results: Women in the highest residential exposure categories for benzene and DPM had an increased prevalence
of cervical dysplasia compared to the lowest exposure category (Benzene: aOR [95% CI] for high exposure = 1.97
[1.07-3.62], very high exposure = 2.30[1.19-4.46]. DPM: aOR [95% CI] for high exposure = 2.83[1.55-5.16], very high
exposure = 2.10[1.07-4.11]). Similarly, women with high residential exposure to PAHs had an increased prevalence of
cervical dysplasia (aOR [95% CI] = 2.46[1.35-4.48]). The highest PAH exposure category was also positively
associated with cervical dysplasia prevalence but was not statistically significant. Assessment of the combined
effect of HAP exposure indicates that exposure to high levels of more than one HAP is positively associated with
cervical dysplasia prevalence (p for trend = 0.004).
Conclusions: Traffic-related HAPs, such as benzene, DPM, and PAHs, are not as well-regulated and monitored as criteria
air pollutants (e.g., ozone), underscoring the need for studies evaluating the role of these toxicants on disease risk. Our
results suggest that exposure to traffic-related air toxics may increase cervical dysplasia prevalence.
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Cervical cancer is the third most common cancer
and the fourth leading cause of cancer-related mortality
among women worldwide [1]. The majority (>85%) of
cervical cancer cases and deaths occur in the developing
world [1], largely due to limited screening programs
which allow for the detection of cervical dysplasia
(precancerous lesions) and early stage cervical cancer
[2-4]. Infection with human papillomavirus (HPV) has
been established as a necessary cause in the development
of cervical cancer; however, most women infected with
HPV do not develop cervical cancer [5,6]. Lifestyle fac-
tors, such as sexual behavior and smoking cigarettes
[7,8], use of oral contraceptives [9,10], high parity [10,11],
as well as co-infections, such as human immunodefi-
ciency virus infection [12], are associated with the devel-
opment of cervical cancer. Taken together these findings
suggest that genetic and/or environmental factors may
play a role in the development of this malignancy [13].
Air pollution is largely composed of automobile emis-
sions, a complex mixture of compounds many of which
are known to adversely affect human health. Benzene,
polycyclic aromatic hydrocarbons (PAHs), and diesel
particulate matter (DPM) are components of automobile
emissions and have been designated by the United States
Environmental Protection Agency (U.S. EPA) as hazard-
ous air pollutants (HAPs) [14]. HAPs are toxic sub-
stances known or suspected to be carcinogenic. In fact,
the International Agency for Research on Cancer has
classified benzene and DPM as carcinogenic compounds,
and many PAHs as possible, probable, or known carcin-
ogens [15-17]. Some studies have suggested that expos-
ure to traffic-related air pollutants, such as benzene,
PAHs, and DPM, is associated with an increased risk for
several types of cancer, including lung cancer [18,19],
brain cancer [20,21], and leukemia [22-24]. The carcino-
genic impact of exposure to traffic-related air pollution
is an ever-increasing public health concern as urbanization
continues to rise, and a greater proportion of the popula-
tion is exposed to higher levels of HAPs.
Exposure to traffic-related HAPs may play a role in
the development of cervical cancer. Occupational ex-
posure to diesel engine exhaust has previously been
shown to be associated with an increased risk of cer-
vical cancer among women [25]. In addition, a recent
study found an increased risk of cervical cancer in Danish
women with higher residential concentration levels of
nitrogen oxides (NOx), a component of automobile en-
gine emissions [21]. The objective of the current study
is to evaluate the association between levels of traffic-
related HAPs and cervical dysplasia, a precursor lesion
for cervical cancer, in a multi-ethnic sample of women
receiving cervical cancer screening and diagnostic ser-
vices in Houston, Texas.Methods
Study population
The study population consisted of women attending
the colposcopy clinics at The University of Texas MD
Anderson Cancer Center and Lyndon B. Johnson General
Hospital in Houston, Texas, between 2000 and 2004, and
enrolled in a multi-center Phase II clinical trial (registered
at www.ClinicalTrials.gov as NCT00511615) to evaluate
fluorescence and reflectance spectroscopy for diagnosing
cervical disease. The detailed data collection methods for
this trial have been previously described [26]. Briefly,
women had to be 18 years of age or older, have no history
of hysterectomy, and not be pregnant to be eligible for en-
rollment in the parent trial. Of those who were eligible and
enrolled in the parent trial, only women who had avail-
able information on HPV infection status and residence
(i.e., address) at the time of diagnosis were eligible for
our study, a secondary data analysis using data collected
during the parent trial. After applying all eligibility criteria,
736 women were included in the current assessment.
Cases (n = 173) included women who were diagnosed with
cervical intraepithelial neoplasia (CIN) I, CIN II, or
CIN III. Women who had a normal Papanicolaou test re-
sult (i.e., not diagnosed with cervical dysplasia or cervical
cancer) served as control subjects (n = 563). Details on
the laboratory methods used to test for HPV status as well
as those used to confirm cervical dysplasia disease status
have been previously described [26]. Epidemiologic data
were obtained from a risk factor interview conducted with
each patient at the time of enrollment on the parent trial.
Women received the standard treatment according to their
colposcopy results. The Institutional Review Boards at the
University of Texas MD Anderson Cancer Center and
Harris Health System approved the protocol for the parent
trial. Informed consent was obtained from all subjects.
Ambient air pollutant concentration levels
Annual concentration estimates of benzene, DPM, and
PAHs were obtained for each census tract from the U.S.
EPA’s 1999 Assessment System for Population Exposure
Nationwide (ASPEN). ASPEN is a computer simulation
model used in the National-Scale Air Toxics Assessment
conducted by the U.S. EPA [27]. The ASPEN model was
derived from the U.S. EPA’s Industrial Source Complex
Long Term model designed to model air pollutant disper-
sion. To generate annual pollutant concentration estimates,
ASPEN uses information on meteorological conditions, the
location and height of pollutant release, rate of release, and
pollutant deposition, reactive decay, and transformation
properties. Other epidemiological studies have used pollu-
tant concentration estimates from ASPEN to evaluate the
effect of HAPs on disease risk [23,28,29].
Residential pollutant levels were determined based on
the ASPEN estimates for the census tract of the subject’s
Table 1 Characteristics of cervical dysplasia cases and







Age in years, mean ± SD 37.0 ± 11.0 43.5 ± 11.8 <0.001
Race/ethnicity, n (%)
Non-Hispanic White 90 (52.0) 296 (52.6) 0.180
Non-Hispanic Black 36 (20.8) 85 (15.1)
Hispanic 39 (22.5) 137 (24.3)
Other 8 (4.6) 45 (8.0)
Education in years, mean ± SD 13.1 ± 1.98 13.4 ± 3.57 0.376
Marital status, n (%)
Never 45 (26.0) 102 (18.2) 0.038
Married/partnered 85 (49.1) 331 (58.9)
Divorced/widowed/separated 43 (24.9) 129 (23.0)
Smoking status, n (%)
Never 108 (62.4) 389 (69.1) 0.101
Ever 65 (37.6) 174 (30.9)
HPV status, n (%)
Positive 129 (74.6) 408 (72.5) 0.587
Negative 44 (25.4) 155 (27.5)
Histology, n (%)
CIN I (mild dysplasia) 141 (81.5)
CIN II (moderate dysplasia) 19 (11.0)
CIN III (severe dysplasia) 13 (7.5)
Clinic, n (%)
MD Anderson Cancer Center 141 (81.0) 481 (85.4) 0.153
Lyndon B. Johnson General Hospital 33 (19.0) 82 (18.6)
Abbreviations: SD, standard deviation; HPV, human papillomavirus; CIN, cervical
intraepithelial neoplasia.
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geocoded and mapped to determine residential census
tracts using ArcGIS software (Esri, Redlands, California).
Benzene, DPM, and PAH levels from ASPEN were catego-
rized using the distribution of the residential HAP levels
among the controls: low or reference exposure (<25th per-
centile), medium exposure (25th-74th percentiles), high
exposure (75th-89th percentiles), and very high exposure
(≥90th percentile). In addition, a HAP composite score
was created to assess the combined effect of exposures to
multiple HAPs on cervical dysplasia. To create the HAP
composite score, each exposure category of each HAP
was assigned a score: 0 = low, 1 =medium, 2 = high, and
3 = very high. The scores from the three HAPs were
then summed for each subject based on their residential
census tract in order to generate the overall HAP com-
posite score, which could range from 0–9.
Statistical analysis
Descriptive statistics were generated to characterize the
demographic variables among the case and control
groups, which included computing means and standard
deviations (SD) for continuous variables and frequency
distributions for categorical variables. Potential differ-
ences between the case and control groups in the distri-
bution of each of the demographic variables were tested
for statistical significance using t tests for continuous
variables and χ2 tests for categorical variables. Correla-
tions between levels of benzene, DPM, and PAHs were
determined using Spearman’s rank correlation. We used
multivariable logistic regression to assess the associations
between HAP levels and cervical dysplasia. Adjusted
prevalence odds ratios (aOR) and 95% confidence inter-
vals (CI) were estimated for each association. Covariates
were selected a priori and included age, race/ethnicity,
years of completed education, HPV infection status
[30,31], and smoking status. All multivariable regression
models were adjusted for these covariates. Univariable lo-
gistic regression analyses were conducted to evaluate the
associate between cervical dysplasia and demographic var-
iables, including age, race/ethnicity, smoking status, and
completed years of education, variables which also serve
as covariates in the adjusted analyses. These results were
included in Additional file 1: Table S1.
Results
There were no statistically significant differences between
the case and control groups in regard to racial makeup,
completed years of education, smoking status, HPV infec-
tion status, and the screening institution (Table 1). Ap-
proximately half of the sample was non-Hispanic white
(52.5%), with a quarter being Hispanic (24.2%) and fewer
being non-Hispanic black (16.0%). This racial/ethnic dis-
tribution approximates the distribution of the populationin the Houston area. The mean (SD) completed years of
education was 13.3 (3.3) years. Approximately one-third of
the sample (32.5%) had a history of smoking. Most of the
subjects (both cases and controls) were positive for HPV
infection (73.0%); 27.0% were HPV negative. The majority
of the sample (84.4%) was screened at the colposcopy
clinic at the University of Texas MD Anderson Cancer
Center, while the remainder (15.6%) was screened at the
Lyndon B. Johnson General Hospital. Cases were younger
(p < 0.001) and more likely to have never been married
(p = 0.04) compared to controls. Cases primarily had CIN I
(81.5%) while the remainder of the cases had moderate to
severe dysplasia (18.5%). All controls were confirmed to
not have cervical dysplasia.
The distributions of selected census tract-level HAP
concentration levels among the control group are pre-
sented in Table 2. The mean benzene exposure level
among the controls was 1.917 μg/m3, with the lowest
Table 2 Distributions of hazardous air pollutants
Pollutant (μg/m3)* Mean 25th percentile 50th percentile 75th percentile 90th percentile
Benzene 1.917 1.415 1.760 2.261 2.977
DPM 2.015 1.413 1.724 2.175 2.794
PAHs 0.011 0.007 0.009 0.013 0.018
Abbreviations: DPM, diesel particulate matter; PAHs, polycyclic aromatic hydrocarbons.
*All concentrations are presented as μg/m3.
B.
A.
Figure 1 Correlations between traffic-related hazardous air
pollutant levels. Scatterplots of (A) diesel particulate matter (DPM)
and benzene, (B) polycyclic aromatic hydrocarbons (PAHs) and
benzene from the 1999 United States’ Environmental Protection
Agency’s (U.S. EPA) Assessment System for Population Exposure
Nationwide’s (ASPEN) model for Texas census tracts included in the
current assessment.
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ure categories representing those living in census tracts
with an estimated average benzene level <1.415 μg/m3
and ≥2.977 μg/m3, respectively. Similarly, the mean level
of DPM and PAHs among the controls was 2.015 μg/m3
and 0.011 μg/m3, respectively. The lowest and highest
exposure categories included those living in census
tracts with an estimated average DPM level <1.413 μg/m3
and ≥2.794 μg/m3, respectively. For PAHs, the lowest
exposure category was <0.007 μg/m3 and the highest ex-
posure category was ≥0.018 μg/m3.
Scatterplots of benzene and each of the other HAPs
(i.e., DPM and PAHs) are presented in Figure 1 to as-
sess correlations between the pollutant levels. Overall,
benzene levels are highly correlated with levels of DPM
(ρ = 0.91, p < 0.0001) and PAHs (ρ = 0.80, p < 0.0001).
However, these correlations were not as strong when re-
stricted to those in the “very high” exposure category.
Specifically, when restricting the correlation analysis to
those in the very high benzene exposure category (n = 83)
the correlations with DPM (ρ = 0.66, p < 0.0001) and PAHs
(ρ = 0.65, p < 0.0001) are attenuated.
The aORs and 95% CIs of the associations between
residential exposure to benzene, DPM and PAH's and
the prevalence of cervical dysplasia are presented in
Table 3. Residential exposure to benzene was associated
with cervical dysplasia (aOR medium exposure = 1.39,
95% CI: 0.83-2.32; aOR high exposure = 1.97, 95% CI:
1.07-3.62; and aOR very high exposure = 2.30, 95% CI:
1.19-4.46) after adjusting for age, race/ethnicity, years
of education, HPV infection status, and smoking. We
also observed a trend with increasing exposure (p for
trend = 0.005). Residential exposure to DPM is positively
associated with cervical dysplasia when comparing high
and very high exposure to low exposure (aOR for high
exposure = 2.83, 95% CI: 1.55-5.16; aOR for very high ex-
posure = 2.10, 95% CI: 1.07-4.11). Compared to low ex-
posure, women living in census tracts with high levels of
PAHs had an increased prevalence of cervical dysplasia
(aOR = 2.46, 95% CI: 1.35-4.48). The effect estimates for
medium or very high exposure to PAHs suggest an in-
creased prevalence of cervical dysplasia; however, these
associations are not statistically significant. When assessing
the combined effect of HAP exposure as defined using the
HAP composite score, there is a positive association withcervical dysplasia prevalence when comparing women
with a higher (score of 3+) HAP composite score to
those with a low composite score (score <3) (aOR for
medium score = 1.78, 95% CI: 1.11-2.84; aOR for high
score = 2.30, 95% CI: 1.28-4.13). All regression analyses
were repeated on a restricted sample that excluded cases
with mild dysplasia, which yielded similar results (data
not shown), and therefore we retained the grouping of
Table 3 Associations between selected traffic-related
hazardous air pollutants and cervical dysplasia
Pollutant Prevalence aOR* [95% CI]
Benzene
Low (<25th percentile) 1.00
Medium (25th-74th percentile) 1.39 [0.83, 2.32]
High (75th-89th percentile) 1.97 [1.07, 3.62]
Very high (≥90th percentile) 2.30 [1.19, 4.46]
P for trend = 0.005
DPM
Low (<25th percentile) 1.00
Medium (25th-74th percentile) 1.41 [0.84, 2.37]
High (75th-89th percentile) 2.83 [1.55, 5.16]
Very high (≥90th percentile) 2.10 [1.07, 4.11]
P for trend = 0.002
PAHs
Low (<25th percentile) 1.00
Medium (25th-74th percentile) 1.30 [0.77, 2.20]
High (75th-89th percentile) 2.46 [1.35, 4.48]
Very high (≥90th percentile) 1.88 [0.94, 3.73]
P for trend = 0.006
HAP composite
Low (score 0–2) 1.00
Medium (score 3–6) 1.78 [1.11, 2.84]
High (score 7–9) 2.30 [1.28, 4.13]
P for trend = 0.004
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; DPM, diesel
particulate matter; PAHs, polycyclic aromatic hydrocarbons; HAP, hazardous
air pollutant.
*Odds ratios adjusted for age, race/ethnicity, education, smoking status, and
status of human papilloma virus (HPV) infection.
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[30,32]. Moreover, regression analyses were repeated
stratifying the sample on HPV infection status, and
the overall results were similar regardless of HPV status
(data not shown).
Discussion
In one of the first studies of its kind, our results indicate
traffic-related HAPs are associated with cervical dyspla-
sia. Specifically, women living in census tracts with high
levels of benzene, DPM, or PAHs were approximately
two to three times more likely to be diagnosed with cer-
vical dysplasia compared to women living in census
tracts with relatively low pollutant levels. We also ob-
served a statistically significant dose–response relationship
between each pollutant and cervical dysplasia prevalence
(p for trend ≤ 0.006 for benzene, PAHs, and DPM). These
findings are notable as cervical dysplasia in conjunction
with chronic HPV infection is a precursor of cervicalcancer. In fact, 18.5% of our cases had medium to severe
dysplasia (CIN II or higher), lesions associated with an
increased risk of progression to cervical cancer, and the
majority of the women in our sample were positive for
HPV infection.
While previous studies have not evaluated the role of
air pollution on the risk of cervical dysplasia, our find-
ings are in keeping with previous reports of an increased
risk of cervical cancer after exposure to traffic-related
pollutants and HAPs [21,25]. In a recent assessment by
Raaschou-Nielsen et al. using data from the Danish Diet
Cancer and Health cohort, residential exposure to NOx
was associated with an increased risk of cervical cancer
(incidence rate ratio = 2.45, 95% CI: 1.01-5.93) [21]. An-
other study conducted in Sweden indicated that oc-
cupational exposure to diesel engine emissions was
associated with an increased incidence of cervical cancer
(standardized incidence ratio = 1.48, 95% CI: 1.17-1.84)
[25]. Our study builds upon these assessments by in-
cluding a multi-ethnic population and evaluating cer-
vical dysplasia rather than cervical cancer. In addition,
there is considerable variation in HAP concentration
levels between the HAP exposure categories defined in
our analysis, which also includes HAP levels positively
associated with adverse health risks [33].
Our findings are consistent with the role of cigarette
smoking on cervical cancer risk. A large body of epi-
demiological evidence supports the association between
cigarette smoking and cervical cancer risk [34-36]. In
fact, when assessing smoking as a predictor of cervical
cancer among women who have a confirmed HPV-
positive status, those who were current or ever smokers
had a two times greater risk of developing cervical can-
cer compared to never smokers (OR = 2.17, 95% CI:
1.46-3.22) [8]. Even passive exposure to cigarette smoke
(i.e., second-hand smoke) may increase the risk of cer-
vical cancer [37]. These previously reported associations
are of note, as cigarette smoke contains carcinogenic
compounds similar to those found in automobile emis-
sions (e.g., benzene and PAHs), and, consequently, the
effect of exposure to traffic-related air pollutants may be
analogous to the effect of smoking on cervical cancer
risk.
While the mechanism underlying the association be-
tween these pollutants and cervical dysplasia is unclear,
there are certain biological pathways that may lead to
dysplasia after exposure to HAPs. For instance, these
HAPs may have genotoxic effects on the cervix. This is
supported by evidence of high levels of PAHs in cervical
mucus and cervical tissue among smokers [38]. PAH-
DNA adducts have also been found in the cervical tissue
of smokers [39]. These adducts have genotoxic proper-
ties, which may lead to cancer. It is unknown if benzene
or DPM has been identified in cervical tissue, however,
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fects [15,16]. Another potential mechanism may be re-
lated to oxidative stress, as these pollutants have been
shown to form reactive oxygen species, leading to DNA
damage [40]. These pollutants may also play a role in
an altered immune environment leading to a state of
chronic inflammation [41,42]. Ultimately, it is suspected
that these pollutants may lead to a state of DNA damage
and/or inflammation, which may facilitate viral integra-
tion, resulting in enhanced cervical carcinogenesis. For
instance, some evidence suggests that PAHs may actu-
ally play a role in the proliferation and persistence of
HPV [43].
There are several limitations to consider when inter-
preting the results presented in this report. First, the
cross-sectional study design and the inclusion of preva-
lent cases of cervical dysplasia make it difficult to assess
temporality in terms of the timing of exposure and the
development of disease. However, it is not uncommon
to evaluate prevalent cases when assessing an asymp-
tomatic condition that requires an invasive screening
technique for detection [26]. Second, ASPEN yields area-
based pollutant concentration estimates and therefore
exposure misclassification is a possibility. Although we
used an area-based exposure measure there are few
sources of population-based exposure assessments of
HAPs. Additionally, ASPEN pollutant concentration esti-
mates have been used extensively in other assessments of
HAPs and adverse health outcomes [23,28,29]. Lastly, it
is not clear if the women in this assessment later devel-
oped more progressive cervical disease or cervical cancer;
however, cervical dysplasia is an important precursor to
cervical cancer and therefore it is important to under-
stand risk factors for cervical dysplasia.
To our knowledge, this study is the first to evaluate
the association of air pollution exposure and predictors
of cervical dysplasia in a racially diverse sample of
women. A growing body of evidence shows that there
are disparities in air pollution exposure among racial
minorities and those with a low socioeconomic status
[44-46]. Racial minorities are more likely to live in urban
areas with higher concentrations of traffic-related air
pollution, therefore, increasing the risk of these groups
to related health effects, such as cervical dysplasia. In
addition, Hispanic and black women are less likely to re-
ceive Pap screening services, have a higher incidence of
cervical cancer, and have poorer survival after a cervical
cancer diagnosis compared to white women in the U.S.
[47-51]. The vulnerability of racial and ethnic minority
groups to air pollution exposure in combination with
lower adherence to screening is a pressing public health
concern.
The results from this study have pertinent implications
for health in the global context. Cervical cancer incidenceand mortality is highest in the developing world, specific-
ally in Africa and Central and South America [1,52]. This
is largely due to the high prevalence of HPV infection in
conjunction with limited access to screening services to de-
tect precancerous lesions and early stage cervical cancer, as
well as the lack of effective dissemination of the HPV vac-
cine and targeted vaccine delivery programs [4,52,53].
Moreover, due to increasing urbanization, specifically in
Latin American cities, a larger portion of the population
living in developing regions is being exposed to high levels
of air pollution largely resulting from rapidly growing road-
way and traffic density in urban areas [54,55]. The in-
creased prevalence of exposure to traffic-related HAPs in
these vulnerable populations may lead to an even higher
incidence of cervical cancer.Conclusions
This is the first study to evaluate the association between
exposure to traffic-related HAPs and cervical dysplasia
prevalence in a multi-ethnic sample of women. Our results
suggest that women with high residential exposure to ben-
zene, DPM, or PAHs have an increased prevalence of cer-
vical dysplasia compared to women with relatively low
exposure to these pollutants. Our findings highlight the
need to continue to identify novel risk factors that contrib-
ute to cervical disease in conjunction with HPV infection.
In addition, our findings may also be important in future
cervical cancer prevention efforts as public health strat-
egies are directed toward the detection, management, and
prevention of cervical dysplasia.Additional file
Additional file 1: Table S1. Associations between demographic
variables and cervical dysplasia: Univariable analyses.
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